LLY

987.92

-1.6%↓

JNJ

227.29

+0.23%↑

ABBV

210.02

-0.19%↓

UNH

385.81

-1.99%↓

AZN

183.55

+1.06%↑

LLY

987.92

-1.6%↓

JNJ

227.29

+0.23%↑

ABBV

210.02

-0.19%↓

UNH

385.81

-1.99%↓

AZN

183.55

+1.06%↑

LLY

987.92

-1.6%↓

JNJ

227.29

+0.23%↑

ABBV

210.02

-0.19%↓

UNH

385.81

-1.99%↓

AZN

183.55

+1.06%↑

LLY

987.92

-1.6%↓

JNJ

227.29

+0.23%↑

ABBV

210.02

-0.19%↓

UNH

385.81

-1.99%↓

AZN

183.55

+1.06%↑

LLY

987.92

-1.6%↓

JNJ

227.29

+0.23%↑

ABBV

210.02

-0.19%↓

UNH

385.81

-1.99%↓

AZN

183.55

+1.06%↑

Kodu・Aktsiate loetelu・Cerus Corp

Cerus Corp

Avatud

SektorTervishoid

2.39 2.58

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

2.33

Max

2.44

Põhinäitajad
By Trading Economics
Sissetulek	527K -1.6M
Müük	2.1M 60M
Aktsiakasum	-0.01
Kasumimarginaal	-2.752
Töötajad	261
EBITDA	1.9M 93K

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+92.31% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	4. aug 2026

Turustatistika
By TradingEconomics
Turukapital	108M 505M
Eelmine avamishind	-0.19
Eelmine sulgemishind	2.39

Uudiste sentiment

By Acuity

36%

64%

81 / 345 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

1.3 / 1.36 Toetus ja vastupanu

Cerus Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

17. mai 2026, 23:53 UTC

Omandamised, ülevõtmised, äriostud

Prudential PLC to Buy Majority Stake in India Life Insurer for $389 Million

15. mai 2026, 22:47 UTC

Kuumad aktsiad

Stocks to Watch: Macy's, Delta, UnitedHealth, NextNRG

15. mai 2026, 22:16 UTC

Omandamised, ülevõtmised, äriostud

Canadian Tribunal Gives Keyera, Plains Until Late June to Rebut Bid to Undo Merger

15. mai 2026, 22:00 UTC

Suurimad hinnamuutused turgudel

Delta Air Shares Rise as Berkshire Hathaway Discloses Stake

15. mai 2026, 18:09 UTC

Suurimad hinnamuutused turgudel

Palo Alto Shares Head for Record-High Close, Analysts See Benefits to Identity Security Pivot

17. mai 2026, 23:50 UTC

Market Talk

Gold Consolidates; May be Weighed by Fed Rate-Hike Expectations -- Market Talk

17. mai 2026, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

17. mai 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Middle East Uncertainty -- Market Talk

17. mai 2026, 23:36 UTC

Market Talk

Oil Rises Amid Prospects of Prolonged Strait of Hormuz Closure -- Market Talk

17. mai 2026, 23:07 UTC

Omandamised, ülevõtmised, äriostud

UOB: Transactions Part of Group's Capital Reallocation Strategy

17. mai 2026, 23:06 UTC

Omandamised, ülevõtmised, äriostud

UOB: Share Sale Agreements Entered With Singland Properties

17. mai 2026, 23:05 UTC

Omandamised, ülevõtmised, äriostud

UOB: Divestments' Aggregate Consideration of S$299M in Cash

17. mai 2026, 22:31 UTC

Omandamised, ülevõtmised, äriostud

Prudential PLC to Fund Stake Acquisition via Internal Resources

17. mai 2026, 22:31 UTC

Omandamised, ülevõtmised, äriostud

Prudential PLC to Acquire Stake for $389 Million

17. mai 2026, 22:30 UTC

Omandamised, ülevõtmised, äriostud

Prudential PLC to Acquire 75% Stake in Bharti Life Insurance

16. mai 2026, 16:27 UTC

Omandamised, ülevõtmised, äriostud

NextEra Is In Talks to Buy Dominion, Report Says. What a Deal Could Mean. -- Barrons.com

16. mai 2026, 15:26 UTC

Omandamised, ülevõtmised, äriostud

NextEra Energy Near Deal for Rival Utility Dominion -- WSJ

16. mai 2026, 08:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15. mai 2026, 22:17 UTC

Omandamised, ülevõtmised, äriostud

Berkshire Boosted Stake in Alphabet in First Quarter, Bought Delta Air, Sold Visa, Mastercard -- Barrons.com

15. mai 2026, 21:59 UTC

Omandamised, ülevõtmised, äriostud

Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying. -- Barrons.com

15. mai 2026, 21:50 UTC

Omandamised, ülevõtmised, äriostud

Berkshire Boosted Stake in Alphabet in First Quarter, Bought Delta Air, Sold Visa, Mastercard -- Barrons.com

15. mai 2026, 21:30 UTC

Omandamised, ülevõtmised, äriostud

Bill Ackman's Pershing Square Bets on Microsoft's AI Ambitions With New Stake -- 4th Update

15. mai 2026, 21:16 UTC

Market Talk

Canada Oil Producers Expect Govt Cash Before Building Pathways Project -- Market Talk

15. mai 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15. mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15. mai 2026, 20:19 UTC

Kuumad aktsiad

Stocks to Watch Recap: Intel, Nvidia, Amgen, LVMH -- WSJ

15. mai 2026, 19:41 UTC

Omandamised, ülevõtmised, äriostud

SanDisk Stock Is Up 494% This Year. Insiders Are Cashing In on the AI-Fueled Surge. -- Barrons.com

15. mai 2026, 19:35 UTC

Market Talk

Oil Futures Settle Higher on Inventory Worries -- Market Talk

15. mai 2026, 19:33 UTC

Market Talk

U.S. Natural Gas Futures Rise as Weather Heats Up -- Market Talk

15. mai 2026, 18:35 UTC

Tulu

Xanadu Quantum Revenue Increases Fourfold. Why the Stock Is Falling. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Cerus Corp Prognoos

Hinnasiht

By TipRanks

92.31% tõus

12 kuu keskmine prognoos

Keskmine 4.5 USD 92.31%

Kõrge 5 USD

Madal 4 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Cerus Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Cerus Corp aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

1.3 / 1.36Toetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

81 / 345 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Cerus Corp

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.